Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2020-06-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement) for Gencurix, which is a formal regulatory filing submitted to the Financial Services Commission (금융위원회) in South Korea. It details the correction of issuance terms and pricing for a public offering of common shares. This type of document is a formal regulatory filing required for capital raising activities and falls under the category of regulatory filings for securities registration.
2020-06-12 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고서) for a 'Securities Registration Statement' (투자설명서) filed by Gencurix. It details changes to the offering price, total offering amount, and underwriting fees following the finalization of the public offering price. This type of filing is a regulatory requirement in South Korea for companies undergoing an IPO or capital raise to update their prospectus. Since it is a formal regulatory filing regarding share issuance and capital structure changes, it falls under the 'Share Issue/Capital Change' category.
2020-06-12 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Gencurix, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It contains detailed tables regarding the number of new shares, purpose of funds, subscription methods, and pricing adjustments. This is a formal regulatory filing regarding capital changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-06-12 Korean
투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '투자설명서' (Investment Prospectus) for Gencurix, Inc. It contains detailed information regarding a public offering, including offering price, subscription period, risk factors (business, financial, and market risks), and management information. This is a formal regulatory document filed in connection with a securities offering (IPO/capital raise) and is not a mere announcement of a report, thus it is classified as a Prospectus/Securities Registration Statement, which falls under the 'Regulatory Filings' category in the provided schema.
2020-06-11 Korean
기업설명회(IR)개최결과
Investor Presentation Classification · 98% confidence The document is a short regulatory filing (844 characters) announcing the results of an Investor Relations (IR) event held by Gencurix. It provides details such as the date, location, attendees, and a summary of the topics covered (company status, business introduction, Q&A). It does not contain the actual presentation slides or full financial report, but rather serves as a formal notification of the event's occurrence and the availability of materials on the KRX disclosure system. Therefore, it is classified as a Regulatory Filing (RNS) as it acts as a formal notice of an event rather than the presentation itself.
2020-06-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties (directors/executives) due to stock option grants and management appointments. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-06-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.